Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Update

Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totalling 3,580,000 shares, a decline of 6.3% from the June 30th total of 3,820,000 shares. Based on an average trading volume of 915,300 shares, the short-interest ratio is presently 3.9 days.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently added to or reduced their stakes in the company. Fifth Third Bancorp grew its holdings in Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares in the last quarter. Tranquility Partners LLC grew its holdings in Acadia Healthcare by 5.3% during the 4th quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock valued at $264,000 after purchasing an additional 170 shares in the last quarter. New York State Teachers Retirement System grew its holdings in Acadia Healthcare by 0.3% during the 1st quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock valued at $6,025,000 after purchasing an additional 200 shares in the last quarter. Blue Trust Inc. grew its holdings in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares in the last quarter. Finally, Commonwealth Equity Services LLC grew its holdings in Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after purchasing an additional 257 shares in the last quarter.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, May 21st. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price objective on the stock in a report on Thursday, April 25th. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Barclays reduced their price target on shares of Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating on the stock in a report on Wednesday, May 15th. Finally, Bank of America reduced their price target on shares of Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $87.56.

Check Out Our Latest Stock Analysis on ACHC

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $64.85 on Thursday. The company’s fifty day simple moving average is $66.89 and its 200-day simple moving average is $73.92. Acadia Healthcare has a 52 week low of $62.04 and a 52 week high of $87.77. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. The company has a market cap of $6.02 billion, a PE ratio of -463.18, a P/E/G ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.75 EPS. As a group, equities research analysts anticipate that Acadia Healthcare will post 3.51 EPS for the current year.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Featured Stories

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.